Free shipping on all orders over $ 500

Motesanib Diphosphate

Cat. No. M1920
Motesanib Diphosphate Structure
Synonym:

AMG 706

Size Price Availability Quantity
10mg USD 180 In stock
50mg USD 550 In stock
100mg USD 950 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT. It is used as the phosphate salt motesanib diphosphate. Motesanib Diphosphate significantly inhibits VEGF-induced cellular proliferation of HUVECs with an IC50 of 10 nM, while displaying little effect at bFGF-induced proliferation with an IC50 of >3,000 nM. Motesanib Diphosphate (AMG 706) induces a dose-dependent tumor regression of established A431 xenografts by selectively targeting neovascularization in tumor cells. Motesanib diphosphate (AMG 706) can induce partial responses in patients with advanced or metastatic differentiated thyroid cancer that is progressive.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 569.44
Formula C22H23N5O.2H3PO4
CAS Number 857876-30-3
Purity >98%
Solubility DMSO 100 mg/mL
Water 100 mg/mL
Storage at -20°C
References

In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humans.
Li C, et al. Drug Metab Dispos. 2009 Jul;37(7):1378-94. PMID: 19372226.

Motesanib diphosphate in progressive differentiated thyroid cancer.
Sherman SI, et al. N Engl J Med. 2008 Jul 3;359(1):31-42. PMID: 18596272.

Related VEGFR/PDGFR Products
SU 5205

SU 5205 is a VEGFR2 inhibitor.

SU-5408

SU-5408 is a potent, cell-permeable inhibitor of mouse VEGFR2 kinase with IC50 of 70 nM.

BFH772

BFH772 is a potent and selective VEGFR2 inhibitor with an IC50 value of 3 nM.

Ranibizumab

Ranibizumab is a monoclonal antibody that inhibits angiogenesis by inhibiting Vascular endothelial growth factor A.

NVP-ACC789

NVP-ACC789 is an inhibitor of human VEGFR-1, VEGFR-2 (mouse VEGFR-2), VEGFR-3 and PDGFR-β with IC50s of 0.38, 0.02 (0.23), 0.18, 1.4 μM, respectively.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: Motesanib Diphosphate, AMG 706 supplier, VEGFR/PDGFR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.